Machiels Alec

CIK 00014966873 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001496687

Recent Transactions

50 trades

Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−11,199→ 0 total
Disposition from Tender
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−250,000→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−27,600→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−14,684→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−3,544→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−7,441→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−17,580→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−5,744→ 0 total
Disposition from Tender
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−384,989→ 0 total
Disposition from Tender
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−150,000→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−3,062→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−5,748→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−8,554→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−7,961→ 0 total
Disposition from Tender
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−11,950→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−121,894→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−27,600→ 0 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2026-01-01+14,684→ 14,684 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-01+7,961→ 384,989 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-01+6,267→ 377,028 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2025-01-01+11,199→ 11,199 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-01+3,341→ 370,761 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-01-01$59.86/sh+5,748→ 5,748 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-11-17$2.67/sh+1,250→ 368,670 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-11-17−1,250→ 0 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-11-17$47.74/sh−1,250→ 367,420 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-10-17$48.50/sh−1,250→ 367,420 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-10-17−1,250→ 1,250 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-10-17$2.67/sh+1,250→ 368,670 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-09-18$2.67/sh+1,250→ 368,670 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-09-18−1,250→ 2,500 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-09-18$45.00/sh−1,250→ 367,420 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-09-15$45.34/sh−1,250→ 367,420 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-09-15$2.67/sh+1,250→ 368,670 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-09-15−1,250→ 3,750 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-07-21−49,779→ 5,000 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-07-21$2.67/sh+49,779→ 367,420 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-07-20−50,000→ 54,779 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-07-20$2.67/sh+50,000→ 317,641 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-07-17$64.79/sh−1,250→ 267,641 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-07-17$2.67/sh+1,250→ 268,891 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-07-17−1,250→ 104,779 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-06-20$2.67/sh+1,250→ 268,891 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-06-20−1,250→ 106,029 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-06-20$88.41/sh−1,250→ 267,641 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-05-17$2.67/sh+1,250→ 268,891 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-05-17$88.66/sh−1,250→ 267,641 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-05-17−1,250→ 107,279 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-04-17−1,250→ 108,529 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-04-17$81.05/sh−1,250→ 267,641 total

Companies

Recent Filings

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451

View on SEC.gov